Tumor compartment-specific effects of P70S6K in early triple negative breast cancer: regulation of antitumor immune response and therapeutic implications

Project Information

P70-IMMUNEBREAST

Grant agreement ID: 893597

DOI

10.3030/893597

Project closed

EC signature date 30 April 2020

Start date 1 January 2021

End date 5 March 2023

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 160 932,48

EU contribution

€ 160 932,48

Coordinated by

FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
Spain

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.

Author(s): Rebeca Jimeno; Silvana Mouron; Roberto Salgado; Sherene Loi; Belén Pérez-Mies; Rodrigo Sánchez-Bayona; Luis Manso; Mario Martínez; Ana Garrido-García; Rosario Serrano-Pardo; Ramón Colomer; Miguel Quintela-Fandino
Published in: Clinical and Translational Oncology, Issue Dec 2022, 2022, ISSN 1699-048X
Publisher: Doyma
DOI: 10.1007/s12094-022-03006-3